These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16314815)

  • 1. [Study of the usefulness of pharmacist consultations for patients on antiretroviral regimens].
    Guerrault MN; Leclerc C; Langevin S; Merian-Brosse L; Brossard D; Welker Y
    Presse Med; 2005 Nov; 34(20 Pt 2):1563-70. PubMed ID: 16314815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations from GESIDA/SEFH/PNS to improve adherence to antiviral treatment (2004)].
    Knobel H; Escobar I; Polo R; Ortega L; Martín-Conde MT; Casado JL; Codina C; Fernández J; Galindo MJ; Ibarra O; Llinas M; Miralles C; Riera M; Fumaz CR; Segador A; Segura F; Chamorro L
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):221-31. PubMed ID: 15826548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
    Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP;
    Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
    Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mean levels of adherence and factors contributing to non-adherence in patients on highly active antiretroviral therapy.
    Williams M; Clarke T; Williams P; Barton EN
    West Indian Med J; 2007 Jun; 56(3):270-4. PubMed ID: 18072411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S
    Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to highly active antiretroviral therapy in the real world: experience of twelve English HIV units.
    Brook MG; Dale A; Tomlinson D; Waterworth C; Daniels D; Forster G
    AIDS Patient Care STDS; 2001 Sep; 15(9):491-4. PubMed ID: 11587635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of HIV outpatient pharmacist prescreening to reduce medication error and assess adherence.
    Seden K; Bradley M; Miller AR; Beadsworth MB; Khoo SH
    Int J STD AIDS; 2013 Mar; 24(3):237-41. PubMed ID: 23562967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.
    Tegegne AS; Ndlovu P; Zewotir T
    BMC Infect Dis; 2018 Feb; 18(1):83. PubMed ID: 29458343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV.
    Henderson KC; Hindman J; Johnson SC; Valuck RJ; Kiser JJ
    AIDS Patient Care STDS; 2011 Apr; 25(4):221-8. PubMed ID: 21323566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.
    Gordillo V; del Amo J; Soriano V; González-Lahoz J
    AIDS; 1999 Sep; 13(13):1763-9. PubMed ID: 10509579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication errors in HIV-infected hospitalized patients: a pharmacist's impact.
    Eginger KH; Yarborough LL; Inge LD; Basile SA; Floresca D; Aaronson PM
    Ann Pharmacother; 2013; 47(7-8):953-60. PubMed ID: 23737513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of treatment complexity on adherence and incidence of blips in HIV/HCV coinfected patients.
    Calvo-Cidoncha E; González-Bueno J; Almeida-González CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2015 Feb; 21(2):153-7. PubMed ID: 25615004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, nature and determinants of pharmaceutical consultations provided in private by Dutch community pharmacists.
    Kooy MJ; Dessing WS; Kroodsma EF; Smits SR; Fietje EH; Kruijtbosch M; De Smet PA
    Pharm World Sci; 2007 Apr; 29(2):81-9. PubMed ID: 17136586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients.
    Morillo-Verdugo R; Robustillo-Cortés MA; Manzano García M; Almeida-González CV
    Rev Esp Quimioter; 2019 Feb; 32(1):40-49. PubMed ID: 30569694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.